Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

OZEMPIC AND MOUNJARO Legal News Articles & Interviews

More Ozempic Side Effects—from Sagging Breasts to Compulsive Behavior

More Ozempic Side Effects—from Sagging Breasts to Compulsive Behavior June 14, 2024. By Jane Mundy.
Santa Clara, CA More side effects—including bizarre behavior—caused by Ozempic and other weight loss drugs have been added to the growing list of downsides, and attorneys predict thousands more Ozempic lawsuits will be filed.
Read [ More Ozempic Side Effects—from Sagging Breasts to Compulsive Behavior ]

Ozempic and Wegovy Linked to Aspiration Pneumonia

Ozempic and Wegovy Linked to Aspiration Pneumonia May 15, 2024. By Jane Mundy.
Los Angeles, CA Patients who have undergone surgeries and endoscopies and taking weight-loss Ozempic, Wegovy and other GLP-1 medications risk aspiration pneumonia. A study conducted by researchers in California found that patients who underwent the procedure were 33 percent more likely to suffer the complication, which can be life-threatening.
Read [ Ozempic and Wegovy Linked to Aspiration Pneumonia ]

Ozempic Babies, Another Side Effect

Ozempic Babies, Another Side Effect April 17, 2024. By Jane Mundy.
Santa Clara, CA Women on birth control or presumed to be infertile have been reporting surprise pregnancies while on Ozempic and similar medications. Referred to as “Ozempic Babies”, they add to increasing concern over the side effects of these diabetes and weight-loss drugs. Healthcare professionals, seeing an association between these medications and unexpected pregnancy on birth control, are warning that these drugs may decrease the effectiveness of oral contraception.
Read [ Ozempic Babies, Another Side Effect ]

Ozempic MDL and Semaglutide Update

Ozempic MDL and Semaglutide Update March 15, 2024. By Jane Mundy.
Philadelphia, PA Fifty-five Ozempic and similar weight loss drug lawsuits have been centralized in Eastern Pennsylvania, with U.S. District Judge Gene E.K. Pratter at the helm of the MDL and scheduled to commence March 14 at the first status conference. The litigation claims that Novo Nordisk's Ozempic, Wegovy and Rybelsus and Eli Lilly's Mounjaro and Trulicity cause gastroparesis and other serious gastrointestinal injuries, and the companies failed to warn patients about the risks associated with GLP-1 receptor agonist medications.
Read [ Ozempic MDL and Semaglutide Update ]

Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim?

Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim? March 8, 2024. By Jane Mundy.
New York, NY As the demand for Ozempic and other semaglutide weight-loss drugs increases, more serious side effects such as stomach paralysis are being reported to medical professionals, the FDA, and attorneys.
Read [ Lawsuits Allege Ozempic Caused Gastroparesis; Do You Have A Claim? ]

Weight Loss Drugmakers Face Stomach Paralysis Lawsuits

Weight Loss Drugmakers Face Stomach Paralysis Lawsuits January 27, 2024. By Jane Mundy.
Santa Clara, CA A drugmaker’s dream is a patient continuing treatment and forever refilling prescriptions--and that spells profit.  Such is the case with the weight loss drugs because discontinuing them leads to regaining lost weight. Ozempic, Mounjaro and Wegovy are star performers, but a drugmaker’s nightmare is the serious side effects that leads to lawsuits, particularly when the manufacturers failed to disclose potential long-term impacts of serious injuries such as gastroparesis.

Read [ Weight Loss Drugmakers Face Stomach Paralysis Lawsuits ]


Request Legal Help Now! - Free